Figure 1 | Leukemia

Figure 1

From: Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways

Figure 1

Expression of lncRNA MEG3 in AML patients and cell lines. (a) RT-qPCR analysis of MEG3 RNA expression in bone marrow of 42 samples from AML patients and CD34+ cells derived from 15 potential donors for allogeneic bone marrow transplantation. (b) RT-qPCR analysis of MEG3 RNA expression in bone marrow from AML patients with/without WT1 or TET2 mutations. (c) PCR analysis of MEG3 RNA expression in AML cell lines. *P<0.05. RT-qPCR, real-time quantitative PCR.

Back to article page